{"count": 27, "results": [{"_id": "33234131", "pmid": 33234131, "pmcid": "PMC7687769", "title": "Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient", "journal": "Cardiovasc Diabetol", "authors": ["Nantsupawat T", "Wongcharoen W", "Chattipakorn SC", "Chattipakorn N"], "date": "2020-11-24T00:00:00Z", "doi": "10.1186/s12933-020-01176-4", "meta_date_publication": "2020 Nov 24", "meta_volume": "19", "meta_issue": "1", "meta_pages": "198", "score": 50280.57, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ was shown to attenuate this adverse remodeling and break in the \"@<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ begets @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@\" process. ", "citations": {"NLM": "Nantsupawat T, Wongcharoen W, Chattipakorn SC, Chattipakorn N. Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient Cardiovasc Diabetol. 2020 Nov 24;19(1):198. PMID: 33234131", "BibTeX": "@article{33234131, title={Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient}, author={Nantsupawat T and Wongcharoen W and Chattipakorn SC and Chattipakorn N}, journal={Cardiovasc Diabetol}, volume={19}, number={1}, pages={198}}"}}, {"_id": "32013885", "pmid": 32013885, "pmcid": "PMC6998172", "title": "Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation", "journal": "BMC Cardiovasc Disord", "authors": ["Liu Y", "Bai F", "Liu N", "Zhang B", "Qin F", "Tu T", "Li B", "Li J", "Ma Y", "Ouyang F", "Liu Q"], "date": "2020-02-03T00:00:00Z", "doi": "10.1186/s12872-020-01359-7", "meta_date_publication": "2020 Feb 3", "meta_volume": "20", "meta_issue": "1", "meta_pages": "50", "score": 50277.258, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reverses the Warburg effect in chronic @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@", "citations": {"NLM": "Liu Y, Bai F, Liu N, Zhang B, Qin F, Tu T, Li B, Li J, Ma Y, Ouyang F, Liu Q. Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation BMC Cardiovasc Disord. 2020 Feb 3;20(1):50. PMID: 32013885", "BibTeX": "@article{32013885, title={Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation}, author={Liu Y and Bai F and Liu N and Zhang B and Qin F and Tu T and Li B and Li J and Ma Y and Ouyang F and Liu Q}, journal={BMC Cardiovasc Disord}, volume={20}, number={1}, pages={50}}"}}, {"_id": "33693008", "pmid": 33693008, "pmcid": "PMC7937645", "title": "Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus", "journal": "Front Med (Lausanne)", "authors": ["Tseng CH"], "date": "2021-02-22T00:00:00Z", "doi": "10.3389/fmed.2020.592901", "meta_date_publication": "2020", "meta_volume": "7", "meta_issue": "", "meta_pages": "592901", "score": 50274.652, "text_hl": "Background: The effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the risk of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ (@<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@) requires confirmation. ", "citations": {"NLM": "Tseng CH. Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus Front Med (Lausanne). 2020;7():592901. PMID: 33693008", "BibTeX": "@article{33693008, title={Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus}, author={Tseng CH}, journal={Front Med (Lausanne)}, volume={7}, pages={592901}}"}}, {"_id": "39195908", "pmid": 39195908, "title": "Repurposing metformin for treatment of atrial fibrillation.", "journal": "Nat Cardiovasc Res", "authors": ["Schwaerzer G"], "date": "2022-11-01T00:00:00Z", "doi": "10.1038/s44161-022-00170-1", "meta_date_publication": "2022 Nov", "meta_volume": "1", "meta_issue": "11", "meta_pages": "972", "score": 50272.746, "text_hl": "Repurposing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for treatment of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@.", "citations": {"NLM": "Schwaerzer G. Repurposing metformin for treatment of atrial fibrillation. Nat Cardiovasc Res. 2022 Nov;1(11):972. PMID: 39195908", "BibTeX": "@article{39195908, title={Repurposing metformin for treatment of atrial fibrillation.}, author={Schwaerzer G}, journal={Nat Cardiovasc Res}, volume={1}, number={11}, pages={972}}"}}, {"_id": "32441464", "pmid": 32441464, "pmcid": "PMC7348162", "title": "Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability", "journal": "J Cell Mol Med", "authors": ["Li B", "Po SS", "Zhang B", "Bai F", "Li J", "Qin F", "Liu N", "Sun C", "Xiao Y", "Tu T", "Zhou S", "Liu Q"], "date": "2020-07-01T00:00:00Z", "doi": "10.1111/jcmm.15407", "meta_date_publication": "2020 Jul", "meta_volume": "24", "meta_issue": "14", "meta_pages": "7751-7766", "score": 50269.355, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ regulates @GENE_ADIPOQ @GENE_403625 @@@adiponectin@@@ signalling in epicardial adipose tissue and reduces @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ vulnerability", "citations": {"NLM": "Li B, Po SS, Zhang B, Bai F, Li J, Qin F, Liu N, Sun C, Xiao Y, Tu T, Zhou S, Liu Q. Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability J Cell Mol Med. 2020 Jul;24(14):7751-7766. PMID: 32441464", "BibTeX": "@article{32441464, title={Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability}, author={Li B and Po SS and Zhang B and Bai F and Li J and Qin F and Liu N and Sun C and Xiao Y and Tu T and Zhou S and Liu Q}, journal={J Cell Mol Med}, volume={24}, number={14}, pages={7751-7766}}"}}, {"_id": "33600005", "pmid": 33600005, "title": "Effect of metformin on outcomes of catheter ablation for atrial fibrillation.", "journal": "J Cardiovasc Electrophysiol", "authors": ["Deshmukh A", "Ghannam M", "Liang J", "Saeed M", "Cunnane R", "Ghanbari H", "Latchamsetty R", "Crawford T", "Batul SA", "Chung E", "Bogun F", "Jongnarangsin K", "Pelosi F", "Chugh A", "Morady F", "Oral E", "Oral H"], "date": "2021-05-01T00:00:00Z", "doi": "10.1111/jce.14954", "meta_date_publication": "2021 May", "meta_volume": "32", "meta_issue": "5", "meta_pages": "1232-1239", "score": 50267.777, "text_hl": "Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on outcomes of catheter ablation for @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@.", "citations": {"NLM": "Deshmukh A, Ghannam M, Liang J, Saeed M, Cunnane R, Ghanbari H, Latchamsetty R, Crawford T, Batul SA, Chung E, Bogun F, Jongnarangsin K, Pelosi F, Chugh A, Morady F, Oral E, Oral H. Effect of metformin on outcomes of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2021 May;32(5):1232-1239. PMID: 33600005", "BibTeX": "@article{33600005, title={Effect of metformin on outcomes of catheter ablation for atrial fibrillation.}, author={Deshmukh A and Ghannam M and Liang J and Saeed M and Cunnane R and Ghanbari H and Latchamsetty R and Crawford T and Batul SA and Chung E and Bogun F and Jongnarangsin K and Pelosi F and Chugh A and Morady F and Oral E and Oral H}, journal={J Cardiovasc Electrophysiol}, volume={32}, number={5}, pages={1232-1239}}"}}, {"_id": "36543101", "pmid": 36543101, "pmcid": "PMC9798075", "title": "New use for an old drug: Metformin and atrial fibrillation", "journal": "Cell Rep Med", "authors": ["Vinciguerra M", "Olier I", "Ortega-Martorell S", "Lip GYH"], "date": "2022-12-20T00:00:00Z", "doi": "10.1016/j.xcrm.2022.100875", "meta_date_publication": "2022 Dec 20", "meta_volume": "3", "meta_issue": "12", "meta_pages": "100875", "score": 50267.617, "text_hl": "New use for an old drug: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@", "citations": {"NLM": "Vinciguerra M, Olier I, Ortega-Martorell S, Lip GYH. New use for an old drug: Metformin and atrial fibrillation Cell Rep Med. 2022 Dec 20;3(12):100875. PMID: 36543101", "BibTeX": "@article{36543101, title={New use for an old drug: Metformin and atrial fibrillation}, author={Vinciguerra M and Olier I and Ortega-Martorell S and Lip GYH}, journal={Cell Rep Med}, volume={3}, number={12}, pages={100875}}"}}, {"_id": "36223777", "pmid": 36223777, "pmcid": "PMC9588904", "title": "Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation", "journal": "Cell Rep Med", "authors": ["Lal JC", "Mao C", "Zhou Y", "Gore-Panter SR", "Rennison JH", "Lovano BS", "Castel L", "Shin J", "Gillinov AM", "Smith JD", "Barnard J", "Van Wagoner DR", "Luo Y", "Cheng F", "Chung MK"], "date": "2022-10-18T00:00:00Z", "doi": "10.1016/j.xcrm.2022.100749", "meta_date_publication": "2022 Oct 18", "meta_volume": "3", "meta_issue": "10", "meta_pages": "100749", "score": 50259.52, "text_hl": "Transcriptomics-based network medicine approach identifies @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a repurposable drug for @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@", "citations": {"NLM": "Lal JC, Mao C, Zhou Y, Gore-Panter SR, Rennison JH, Lovano BS, Castel L, Shin J, Gillinov AM, Smith JD, Barnard J, Van Wagoner DR, Luo Y, Cheng F, Chung MK. Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation Cell Rep Med. 2022 Oct 18;3(10):100749. PMID: 36223777", "BibTeX": "@article{36223777, title={Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation}, author={Lal JC and Mao C and Zhou Y and Gore-Panter SR and Rennison JH and Lovano BS and Castel L and Shin J and Gillinov AM and Smith JD and Barnard J and Van Wagoner DR and Luo Y and Cheng F and Chung MK}, journal={Cell Rep Med}, volume={3}, number={10}, pages={100749}}"}}, {"_id": "32844365", "pmid": 32844365, "title": "Activation of AMP-Activated Protein Kinases Prevents Atrial Fibrillation.", "journal": "J Cardiovasc Transl Res", "authors": ["Ozcan C", "Dixit G", "Li Z"], "date": "2021-06-01T00:00:00Z", "doi": "10.1007/s12265-020-10069-6", "meta_date_publication": "2021 Jun", "meta_volume": "14", "meta_issue": "3", "meta_pages": "492-502", "score": 50254.746, "text_hl": "We tested the efficacy of AMP-activated protein kinase (AMPK) activators, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@, in primary prevention of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ in cardiac-specific @GENE_STK11 @GENE_20869 @@@liver kinase B1@@@ (@GENE_STK11 @GENE_20869 @@@LKB1@@@) knockout (KO) @SPECIES_10090 @@@mouse@@@ model of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@. ", "citations": {"NLM": "Ozcan C, Dixit G, Li Z. Activation of AMP-Activated Protein Kinases Prevents Atrial Fibrillation. J Cardiovasc Transl Res. 2021 Jun;14(3):492-502. PMID: 32844365", "BibTeX": "@article{32844365, title={Activation of AMP-Activated Protein Kinases Prevents Atrial Fibrillation.}, author={Ozcan C and Dixit G and Li Z}, journal={J Cardiovasc Transl Res}, volume={14}, number={3}, pages={492-502}}"}}, {"_id": "36933806", "pmid": 36933806, "title": "Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea.", "journal": "Diabetes Res Clin Pract", "authors": ["Kim S", "Park SY", "Kim B", "Min C", "Cho W", "Yon DK", "Kim JY", "Han KD", "Rhee EJ", "Lee WY", "Rhee SY"], "date": "2023-04-01T00:00:00Z", "doi": "10.1016/j.diabres.2023.110626", "meta_date_publication": "2023 Apr", "meta_volume": "198", "meta_issue": "", "meta_pages": "110626", "score": 50253.836, "text_hl": "RESULTS: Of the @SPECIES_9606 @@@patients@@@ included (mean age, 62 +- 11 years; 60 % @SPECIES_9606 @@@men@@@), 89,125 were newly diagnosed with @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@) alone (hazard ratio [HR] 0.959, 95 % CI 0.935-0.985) and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ combination therapy (HR < 1) significantly decreased the risk of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ compared to the no-medication group. ", "citations": {"NLM": "Kim S, Park SY, Kim B, Min C, Cho W, Yon DK, Kim JY, Han KD, Rhee EJ, Lee WY, Rhee SY. Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea. Diabetes Res Clin Pract. 2023 Apr;198():110626. PMID: 36933806", "BibTeX": "@article{36933806, title={Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea.}, author={Kim S and Park SY and Kim B and Min C and Cho W and Yon DK and Kim JY and Han KD and Rhee EJ and Lee WY and Rhee SY}, journal={Diabetes Res Clin Pract}, volume={198}, pages={110626}}"}}]}